patientrecruitmenttraining.blogspot.com
Patient Recruitment Training: Patient Recruitment Training for Clinical Sites
http://patientrecruitmenttraining.blogspot.com/2005/11/patient-recruitment-training-for.html
View my complete profile. Monday, November 14, 2005. Patient Recruitment Training for Clinical Sites. Several options exist to ensure that clinical sites staff is well-trained and knowledgeable about recruiting subjects for clinical research. This information has been published by the International Biopharmaceutical Association www.ibpassociation.org. Please note this information does not give any medical advice. ClinQua CRO ( www.clinqua.com. Biorole Free Resumes Data Base ( www.biorole.com. File Format...
coveragefdafinancialdisclosurerules.blogspot.com
Coverage under FDA Financial Disclosure Rules: November 2005
http://coveragefdafinancialdisclosurerules.blogspot.com/2005_11_01_archive.html
Coverage under FDA Financial Disclosure Rules. Tuesday, November 22, 2005. Who and What is covered under FDA Financial Disclosure Rules? As written by Shilpa Sadekar. Who is responsible for signing the financial certification/disclosure forms? The forms are to be signed and dated by a responsible corporate official or representative of the applicant (e.g., the chief financial officer) [2]. How is the Sponsor Defined? What is the responsibility of the IND/IDE sponsor for obtaining financial information fr...
patientrecruitmenttraining.blogspot.com
Patient Recruitment Training: November 2005
http://patientrecruitmenttraining.blogspot.com/2005_11_01_archive.html
View my complete profile. Patient Recruitment Training for Clinical Sites. Monday, November 14, 2005. Patient Recruitment Training for Clinical Sites. Several options exist to ensure that clinical sites staff is well-trained and knowledgeable about recruiting subjects for clinical research. This information has been published by the International Biopharmaceutical Association www.ibpassociation.org. Please note this information does not give any medical advice. ClinQua CRO ( www.clinqua.com. File Format:...
coveragefdafinancialdisclosurerules.blogspot.com
Coverage under FDA Financial Disclosure Rules: Who and What is covered under FDA Financial Disclosure Rules?
http://coveragefdafinancialdisclosurerules.blogspot.com/2005/11/who-and-what-is-covered-under-fda.html
Coverage under FDA Financial Disclosure Rules. Tuesday, November 22, 2005. Who and What is covered under FDA Financial Disclosure Rules? As written by Shilpa Sadekar. Who is responsible for signing the financial certification/disclosure forms? The forms are to be signed and dated by a responsible corporate official or representative of the applicant (e.g., the chief financial officer) [2]. How is the Sponsor Defined? What is the responsibility of the IND/IDE sponsor for obtaining financial information fr...
drugapprovalsafetynorthamerica.blogspot.com
Drug Approval Safety in North America: Patient Safety and the Drug Approval Process in North America
http://drugapprovalsafetynorthamerica.blogspot.com/2005/11/patient-safety-and-drug-approval.html
Drug Approval Safety in North America. Monday, November 28, 2005. Patient Safety and the Drug Approval Process in North America. As written by Samna Ghani. The recent withdrawal of Vioxx from the market has brought the Food and Drug Administration (FDA) and its drug approval process in limelight and does raise the question: Does the drug approval process in USA and Canada really guarantee a patient's safety? How much does a general consumer know was identified, studied or examined about a particular drug?
drugapprovalsafetynorthamerica.blogspot.com
Drug Approval Safety in North America: November 2005
http://drugapprovalsafetynorthamerica.blogspot.com/2005_11_01_archive.html
Drug Approval Safety in North America. Monday, November 28, 2005. Patient Safety and the Drug Approval Process in North America. As written by Samna Ghani. The recent withdrawal of Vioxx from the market has brought the Food and Drug Administration (FDA) and its drug approval process in limelight and does raise the question: Does the drug approval process in USA and Canada really guarantee a patient's safety? How much does a general consumer know was identified, studied or examined about a particular drug?
